Phosphopyridoxal cyclic compounds with histamine and histidine. 6: The formation of phosphopyridoxal cyclic compounds with histamine and histidine in the presence of biological material.
We have studied the dynamics of cyclic compound formation between histamine or histidine and pyridoxal 5'-phosphate (Hi-PLP or His-PLP) in incubates of rat gastric mucosa histidine decarboxylase (HD), rat intestinal diamine oxidase (DAO) or homogenates of either rat liver, intestine or gastric mucosa. For gastric mucosa HD, liver and gastric mucosa homogenates, the rate of cyclization was slightly decreased; however, the rate was significantly inhibited with intestinal DAO or intestinal homogenate. Binding of PLP by tissue components was measured; free PLP was bound abundantly by rat intestinal DAO and by rat intestinal homogenate. A possible mechanism by which intestinal tissues inhibit cyclic compound formation is discussed.
D006631:Amine Oxidase (Copper-Containing) / Q000378:metabolism; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D003500:Cyclization; D005753:Gastric Mucosa / Q000378:metabolism; D006632:Histamine / Q000378:metabolism*; D006639:Histidine / Q000378:metabolism*; D006640:Histidine Decarboxylase / Q000378:metabolism; D066298:In Vitro Techniques; D007413:Intestinal Mucosa / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D011732:Pyridoxal Phosphate / Q000378:metabolism*; D051381:Rats
D000963:Antimetabolites; D006639:Histidine; D011732:Pyridoxal Phosphate; D006632:Histamine; D006631:Amine Oxidase (Copper-Containing); D006640:Histidine Decarboxylase